FDA Approved: JEMPERLI — Original Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved JEMPERLI (dostarlimab) from the original application by GlaxoSmithKline for adult patients with mismatch repair deficiency recurrent or advanced en…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• JEMPERLI (DOSTARLIMAB)

Snippet

ORIG AP for JEMPERLI (DOSTARLIMAB)